The $13 billion figure shows the strength of the company’s railroad, energy and manufacturing, service, and retailing units.

In a “shrinkflation” world, investors might want to stop and appreciate the stock market, which is giving them more for less.

The state’s light regulation and low taxes are luring dozens of big companies. It’s also setting up a water crisis and a ...

Democrats and Republicans are still at odds over the Clarity Act, which includes putting most crypto trading outside the ...

Meta Platforms was ordered to pay $942 million in a New Mexico case over harm to children, but investors may be more ...

I agree to the Terms of Use , Privacy Notice and Cookie Notice. I would like to receive updates and special offers from Dow ...

Doximity stock surges, even after the medical networking and telehealth company’s earnings miss analysts’ targets.

Dave lost 97% of its value before a 1-for-32 reverse split. Now the fintech stock has surged back. As SPACs mount a comeback, ...

I would like to receive updates and special offers from Dow Jones and affiliates. I can unsubscribe at any time.

Replimune secures FDA approval for Tudriqev on its third attempt, making it the company’s first product on the market.

Positive readouts in cancer and cardiac drug trials could keep the biotech rally going. Sizing up the stakes for Novartis, ...

I agree to the Terms of Use , Privacy Notice and Cookie Notice.